Gastrointestinal Stromal Tumors (GIST), previously regarded as rare, are now being recognized as more prevalent than initially thought. Research indicates that in Europe, approximately 14 to 20 individuals per million are affected by GISTs, although experts suspect that this estimate could be underreported. While these tumors typically have a genetic basis, there are cases where genetic factors are not involved. The prognosis and treatment options for GISTs heavily rely on factors such as the tumor’s size and location within the gastrointestinal system.
Understanding Interstitial Cells of Cajal
Gastrointestinal stromal tumors (GISTs) commonly occur in the stomach and small intestine, but they have the potential to develop in any part of the gastrointestinal (GI) tract. Scientists have identified a specific type of cells, known as interstitial cells of Cajal, as the likely origin of GISTs. These cells play a crucial role in maintaining the normal functioning of the gut by aiding in nutrient absorption and facilitating the movement of food through the digestive system. However, when abnormalities arise within these cells, various gastrointestinal disorders, including GISTs, can occur.
Tumor Characteristics
Gastrointestinal stromal tumors (GISTs) can vary in their nature, as they are not always cancerous. However, when they are malignant, they are often categorized as soft tissue sarcomas. The majority of GISTs are localized and typically measure less than 2 inches in size. However, if they appear in the small intestine, they may be larger and have a higher tendency to spread to other organs. It is worth noting that even when metastasis occurs, it can take a considerable amount of time. In fact, there have been cases where the primary tumor took 42 years to spread to the liver.